Literature DB >> 12596051

FMR1 haplotype analyses among Indians: a weak founder effect and other findings.

Deepti Sharma1, Meena Gupta, B K Thelma.   

Abstract

This study on allelic/haplotypic fragile X associations evaluated using STR (DXS548, FRAXAC1, FRAXAC2) and SNP (ATL1) markers flanking the (CGG)(n) locus of FMR1is the first report from the large ethnically complex Indian population. Results have been compared with allele/haplotype distributions reported for other major ethnic groups, including White Caucasians, Africans, and Pacific Asians. Though overall allele frequency distributions at the individual loci are more similar to Western Caucasians compared with others, significant differences are observed in haplotypic associations with the mutated X. The striking findings are: (1) high diversity and heterozygosity of haplotypes among fragile X chromosomes ( n=40) and controls ( n=262), including four haplotypes found exclusively in this study sample; (2) weak association of DXS548-FRAXAC1-FRAXAC2 haplotypes, 2-1-3, 6-3-3+ and 7-4-6+ with the disorder, and absence of White Caucasian fragile X haplotypes 6-4-4 and 6-4-5; (3) weak founder effect for the fragile X expansion mutation in the Indians; (4) lack of a continuum of haplotype-based FMR1 alleles between intermediate (CGG)(n) size ranges and expanded alleles; (5) exclusion of ATL1 as a candidate genetic indicator of FMR1 instability. The high STR-based haplotype diversity observed among fragile X lineages, irrespective of ethnic alliances, strongly suggests the inappropriateness of using STR haplotypes to infer predisposition to instability among ethnically separated fragile X pedigrees and may reiterate the need for identifying newer SNPs from this region to not only determine true founder effects for the fragile X mutation, but also decipher possible mechanisms leading to CGG instability.

Entities:  

Mesh:

Year:  2002        PMID: 12596051     DOI: 10.1007/s00439-002-0872-6

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  46 in total

Review 1.  Dynamic mutation: possible mechanisms and significance in human disease.

Authors:  R I Richards; G R Sutherland
Journal:  Trends Biochem Sci       Date:  1997-11       Impact factor: 13.807

2.  Pre-Caucasoid and Caucasoid genetic features of the Indian population, revealed by mtDNA polymorphisms.

Authors:  G Passarino; O Semino; L F Bernini; A S Santachiara-Benerecetti
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

3.  Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype.

Authors:  T C Falik-Zaccai; E Shachak; M Yalon; Z Lis; Z Borochowitz; J N Macpherson; D L Nelson; E E Eichler
Journal:  Am J Hum Genet       Date:  1997-01       Impact factor: 11.025

4.  Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.

Authors:  P C Patsalis; C Sismani; J A Hettinger; I Boumba; I Georgiou; G Stylianidou; V Anastasiadou; R Koukoulli; G Pagoulatos; M Syrrou
Journal:  Am J Med Genet       Date:  1999-05-28

5.  Frequency of the fragile X syndrome in Chinese mentally retarded populations is similar to that in Caucasians.

Authors:  N Zhong; W Ju; W Xu; L Ye; Y Shen; G Wu; S H Chen; R Jin; X F Hu; A Yang; X Liu; P Poon; C Pang; Y Zheng; L Song; P Zhao; B Fu; H Gu; W T Brown
Journal:  Am J Med Genet       Date:  1999-05-28

6.  Population studies of the fragile X: a molecular approach.

Authors:  P A Jacobs; H Bullman; J Macpherson; S Youings; V Rooney; A Watson; N R Dennis
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

7.  Fragile X founder effects and new mutations in Finland.

Authors:  N Zhong; E Kajanoja; B Smits; J Pietrofesa; D Curley; D Wang; W Ju; S Nolin; C Dobkin; M Ryynänen; W T Brown
Journal:  Am J Med Genet       Date:  1996-07-12

8.  Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome.

Authors:  E E Eichler; J N Macpherson; A Murray; P A Jacobs; A Chakravarti; D L Nelson
Journal:  Hum Mol Genet       Date:  1996-03       Impact factor: 6.150

9.  Striking founder effect for the fragile X syndrome in Finland.

Authors:  C Oudet; H von Koskull; A M Nordström; M Peippo; J L Mandel
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

10.  Evidence of founder chromosomes in fragile X syndrome.

Authors:  R I Richards; K Holman; K Friend; E Kremer; D Hillen; A Staples; W T Brown; P Goonewardena; J Tarleton; C Schwartz
Journal:  Nat Genet       Date:  1992-07       Impact factor: 38.330

View more
  2 in total

1.  Molecular evidence of founder effects of fatal familial insomnia through SNP haplotypes around the D178N mutation.

Authors:  Ana B Rodríguez-Martínez; Miguel A Alfonso-Sánchez; José A Peña; Raquel Sánchez-Valle; Inga Zerr; Sabina Capellari; Miguel Calero; Juan J Zarranz; Marian M de Pancorbo
Journal:  Neurogenetics       Date:  2008-03-18       Impact factor: 2.660

2.  Haplotype Analysis of DXS548 and FRAXAC1 Microsatellite Loci in Iranian Patients with Fragile X Syndrome.

Authors:  Seyed Ahmad Aleyasin; Fatemeh Salamat; Mojgan Mirakhori
Journal:  Iran J Child Neurol       Date:  2018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.